Nel ASA's Interim Captain Faces a Defining Test as New Electrolyser Economics Take Shape
Published on 08/01/2026 at 03:13 | Redaktion boerse-global.de
The clock is ticking at Nel ASA, and not just on the trading floor. With CEO Håkon Volldal serving out a six-month notice period that runs until January 2027, the Norwegian hydrogen specialist is navigating a leadership transition at the precise moment it needs to commercialise a new technology platform. The shares closed Friday's European session at €0.1942, down 0.92 percent, leaving the company roughly 47 percent below its 52-week high of €0.3655 reached on 25 May 2026.
A Technical Picture Caught Between Support and Resistance
The stock's technical positioning reflects the broader uncertainty. Nel currently trades about 9.34 percent beneath its 200-day moving average of €0.2142 — a level that once served as reliable support but has now transformed into overhead resistance since the summer. The 14-day relative strength index sits at 37.4, edging toward oversold territory without yet flashing a decisive buy signal. It is a familiar limbo: too weak for optimism, too stable for panic.
The critical marker to watch remains the 52-week low of €0.1731. A stabilisation above that floor, combined with the growing order book, could set the stage for a recovery phase. But a decisive break lower would likely invite fresh technical selling. On the upside, a move through the 50-day average at €0.2359 would be required to confirm any meaningful trend reversal, with the psychological €0.20 level serving as the first intermediate hurdle.
The PA-Series Pitch: Halving the Cost of Green Hydrogen
While the share price wrestles with its moving averages, management is pinning operational hopes on the new pressurised alkaline electrolyser platform, the PA-Series, which launched in the second quarter of 2026. The technology targets large-scale industrial projects with a compelling cost proposition: for 25-megawatt installations, Nel calculates a turnkey full-cost price of under $1,450 per kilowatt. That compares with an industry benchmark of roughly $3,000 per kilowatt for comparable hydrogen projects — a potential halving of capital requirements that could unlock industrial-scale developments previously deemed uneconomical.
Should investors sell immediately? Or is it worth buying Nel ASA?
The fully automated factory at Herøya in Norway is expected to convert these cost advantages into gigawatt-scale orders for 2026 and 2027. The company has also secured federal and state funding support for a planned 4-gigawatt manufacturing facility in Michigan, positioning Nel to benefit from North American hydrogen subsidies should the project move closer to a final investment decision.
A Record Backlog Meets a Leadership Vacuum
The second-quarter numbers paint a divided picture. Order intake grew by triple digits year-on-year, driven primarily by the PEM electrolyser business, lifting the total backlog to NOK 1,213 million. Yet overall revenue declined compared with the same period last year. That gap between a swelling order book and a shrinking top line is the central question hanging over the stock: can Nel convert its record pipeline into actual revenue growth before the leadership transition concludes in early 2027?
The board insists the strategic direction remains unchanged following Volldal's departure to packaging group Elopak. Nel has repositioned itself as a pure-play electrolyser company following the spin-off of its hydrogen refuelling division, Cavendish Hydrogen, allowing capital to be directed more deliberately into PEM and alkaline technologies. But investors remain wary of a "lame duck" leadership dynamic, concerned that major strategic decisions and project execution could stall during the search for a permanent successor.
The Bear Case: Cash Burn and Execution Risk
The risks extend beyond the corner office. Persistent net losses, compounded by one-off costs such as the recently concluded settlement with Iwatani Corporation, continue to drain cash reserves that are already thinner than in previous years. The company needs large final investment decisions from customers to utilise the Herøya capacity — precisely the kind of commitments that may prove harder to secure while the leadership question remains unresolved.
Nel ASA at a turning point? This analysis reveals what investors need to know now.
Should market scepticism over the management situation persist, Nel could struggle to win those crucial project approvals, creating a self-reinforcing cycle of underutilisation and financial strain.
What Comes Next
The next concrete test arrives on 20 October 2026, when Nel reports third-quarter results. Investors will scrutinise whether capacity utilisation is improving and whether the CEO search is making progress. Until then, the shares are likely to oscillate between technical recovery hopes and the persistent overhang of leadership uncertainty. The 52-week low at €0.1731 remains the line in the sand — hold it, and the record order book offers a credible stabilisation narrative; lose it, and the bears take control.
Ad
Nel ASA Stock: New Analysis - 1 August
Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
